Zhichao Kong
机构:Shandong University, Ministry of Education
发表论文 6 篇 · 总被引 120 次 · h-index 3
代表论文
- Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice (2024 · Science Advances · 被引 53)
- An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma (2025 · Nature Cancer · 被引 43)
- In vivo CAR-Tfh cell reprogramming restores tolerance in a mouse model of autoimmune hepatitis (2026 · Cell stem cell · 被引 5)
- Synthetic cleavage-resistant TREM2 boosts macrophage efferocytosis to treat inflammatory diseases (2026 · Cell Reports Medicine · 被引 3)
- Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice (2026 · Journal of Controlled Release · 被引 2)
- Synthetic Disaggregators Enhance Central‐Peripheral Amyloid‐β Clearance in Alzheimer's Disease (2026 · Advanced Materials · 被引 1)